Page last updated: 2024-09-04
cd 437 and 2-naphthol
cd 437 has been researched along with 2-naphthol in 1 studies
Compound Research Comparison
Studies (cd 437) | Trials (cd 437) | Recent Studies (post-2010) (cd 437) | Studies (2-naphthol) | Trials (2-naphthol) | Recent Studies (post-2010) (2-naphthol) |
---|---|---|---|---|---|
134 | 0 | 26 | 4,120 | 16 | 1,458 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ausubel, FM; Conery, AL; Fricke, N; Fuchs, BB; Gao, H; Gilmore, MS; Hendricks, GL; Keohane, CE; Kim, W; Lee, K; Mylonakis, E; Pan, W; Rajamuthiah, R; Shen, S; Steele, AD; Van Tyne, D; Vlahovska, PM; Wuest, WM; Zhu, W | 1 |
Other Studies
1 other study(ies) available for cd 437 and 2-naphthol
Article | Year |
---|---|
A new class of synthetic retinoid antibiotics effective against bacterial persisters.
Topics: Animals; Anti-Bacterial Agents; Benzoates; Caenorhabditis elegans; Cell Death; Cell Line; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Gentamicins; Humans; Lipid Bilayers; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Mutation; Naphthols; Retinoids; Staphylococcal Infections | 2018 |